<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li J</submitter><funding>the Major Science and Technology Project Incubation Program of Bengbu Medical College</funding><funding>National Natural Science Foundation of China</funding><funding>the Outstanding Youth Fund Project of the First Affiliated Hospital of Bengbu Medical College</funding><pagination>e13292</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9528773</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(10)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Crohn's disease (CD) mesenteric adipose tissue (MAT) inflammation affects enteritis through the interaction between the mesentery and intestine, and we previously found that poorly differentiated mesenteric adipocytes were related to its inflammatory features. Pygopus2 (Pygo2) is a key negative regulator of adipocyte differentiation. We aimed to determine whether Pygo2 participates in CD mesenteric lesions and whether Pygo2 knockdown would be beneficial in a CD model (Il-10&lt;sup>-/-&lt;/sup> mice).&lt;h4>Methods&lt;/h4>Pygo2 expression in MAT from control and CD patients and Il-10&lt;sup>-/-&lt;/sup> mice was measured by immunohistochemistry. Lentiviral transfection was used to regulate Pygo2 expression in Il-10&lt;sup>-/-&lt;/sup> mice, and the effects on mesenteric adipocyte differentiation</pubmed_abstract><journal>Cell proliferation</journal><pubmed_title>Pygopus2 ameliorates mesenteric adipocyte poor differentiation to alleviate Crohn's disease -like colitis via the Axin2/GSK3β pathway.</pubmed_title><pmcid>PMC9528773</pmcid><funding_grant_id>2019byyfyyq02</funding_grant_id><funding_grant_id>2020byfy003</funding_grant_id><funding_grant_id>2019byyfyjq01</funding_grant_id><funding_grant_id>81902078</funding_grant_id><funding_grant_id>82070561</funding_grant_id><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Shi R</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Zuo L</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Cheng Y</pubmed_authors><pubmed_authors>Ge S</pubmed_authors><pubmed_authors>Yang Z</pubmed_authors><pubmed_authors>Hu J</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Geng Z</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Song X</pubmed_authors><pubmed_authors>Nie W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pygopus2 ameliorates mesenteric adipocyte poor differentiation to alleviate Crohn's disease -like colitis via the Axin2/GSK3β pathway.</name><description>&lt;h4>Objectives&lt;/h4>Crohn's disease (CD) mesenteric adipose tissue (MAT) inflammation affects enteritis through the interaction between the mesentery and intestine, and we previously found that poorly differentiated mesenteric adipocytes were related to its inflammatory features. Pygopus2 (Pygo2) is a key negative regulator of adipocyte differentiation. We aimed to determine whether Pygo2 participates in CD mesenteric lesions and whether Pygo2 knockdown would be beneficial in a CD model (Il-10&lt;sup>-/-&lt;/sup> mice).&lt;h4>Methods&lt;/h4>Pygo2 expression in MAT from control and CD patients and Il-10&lt;sup>-/-&lt;/sup> mice was measured by immunohistochemistry. Lentiviral transfection was used to regulate Pygo2 expression in Il-10&lt;sup>-/-&lt;/sup> mice, and the effects on mesenteric adipocyte differentiation</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-19T17:38:32.707Z</modification><creation>2025-04-19T17:38:32.707Z</creation></dates><accession>S-EPMC9528773</accession><cross_references><pubmed>35707871</pubmed><doi>10.1111/cpr.13292</doi></cross_references></HashMap>